NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Nanobiotix S.A. Data evaluating safety and early signals of efficacy including updated local PFS from the completed dose ...
Onconetix announces new clinical data for Proclarix to be presented at EAU
Onconetix (ONCO) announced that an abstract has been accepted for presentation at the 2025 European Association of Urology, EAU, congress ...
EurekAlert!2d
Jessica Adsit, MS, CGC is presented the 2025 ACMG Foundation Genetic Counselor Best Abstract Award
Jessica Adsit, MS, CGC is the 2025 recipient of the. The ACMG Foundation for Genetic and Genomic Medicine presented Ms. Adsit this award for her platform presentation, “Next Generation Sequencing in ...
Arts Knoxville2d
Review: CBT’s ‘Failure: A Love Story’ — Whimsical and Wise
BY ALAN SHERROD Equal parts existentialism and comically whimsical narrative, Philip Dawkins’ Failure: A Love Story, which ...
FAD Magazine2d
Abstract Erotic: Louise Bourgeois, Eva Hesse, Alice Adams – New Exhibition
Louise Bourgeois, Eva Hesse, Alice Adams is the first exhibition to bring together sculpture by three pioneering artists of the 20th century ...
Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025
Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced two upcoming ...
Ophthalmology Times3d
Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.